Superworth

Bristol-Myers Squibb shares outstanding BMY

Diluted shares outstanding, averaged over each quarter, from 2009.

Latest quarter, to Sep 30, 2026
2.1B
On a year earlier
+0.7%
more shares

Bristol-Myers Squibb had 2.1B diluted shares outstanding on average in Q3 FY26, the quarter to Sep 30, 2026.

That is 0.7% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY20252B+0%
FY20242B+0%
FY20232B−4%
FY20222.1B−4%
FY20212.2B−1%
FY20202.3B+18%
FY20191.9B+17%
FY20181.6B+0%
FY20171.6B−3%
FY20161.7B+1%
FY20151.7B−0%
FY20141.7B+0%
FY20131.7B+1%
FY20121.7B−3%
FY20111.7B−1%

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q3 FY262.1B+1%
Q2 FY262B+0%
Q1 FY262B+0%
Q4 FY252B+0%
Q3 FY252B+0%
Q2 FY252B+0%
Q1 FY252B+1%
Q4 FY242B+0%
Q3 FY242B−2%
Q2 FY242B−3%
Q1 FY242B−4%
Q4 FY232B−4%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Bristol-Myers Squibb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.